Daniel S. Hoverman serves as Executive at OncBioMune Pharmaceuticals, Inc, where they oversee executive responsibilities. Since joining the company, Daniel S. Hoverman has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 18, 2016 involved receiving (via award) 60,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 18, 2016 | OBMP | $0 | Award | 60,000 | $N/A | Discretionary |
Daniel S. Hoverman currently holds 60,000 shares of OncBioMune Pharmaceuticals, Inc (OBMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel S. Hoverman has been a net neutral trader of OBMP stock. They have purchased $0 and sold $0 worth of shares.
Daniel S. Hoverman's most recent insider trade was on Feb 18, 2016, when they sold 60,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted